Optical coherence tomography in children with inherited retinal disease

References

• Heath Jeffery RC, Mukhtar SA, McAllister IL et al. Inherited retinal diseases are the most common cause of blindness in the working-age population in Australia. Ophthalmic Genet 2021; 42: 431–439. doi:10.1080/13816810.2021.1913610.
   PubMed Web of Science ®Google Scholar
• Boye SE, Boye SL, Lewin AS et al. A comprehensive review of retinal gene therapy. Mol Ther 2013; 21: 509–519. doi:10.1038/mt.2012.280.
   PubMed Web of Science ®Google Scholar
• Jacobson SG, Cideciyan AV, Ratnakaram R et al. Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol 2012; 130: 9–24. doi:10.1001/archophthalmol.2011.298.
   PubMed Web of Science ®Google Scholar
• MacLaren RE, Groppe M, Barnard AR et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. Lancet 2014; 383: 1129–1137. doi:10.1016/S0140-6736(13)62117-0.
   PubMed Web of Science ®Google Scholar
• Britten-Jones AC, Jin R, Gocuk SA et al. The safety and efficacy of gene therapy treatment for monogenic retinal and optic nerve diseases: a systematic review. Genet Med 2022; 24: 521–534. doi:10.1016/j.gim.2021.10.013.
   PubMed Web of Science ®Google Scholar
• Britten‐Jones AC, O’Hare F, Edwards TL et al. Victorian evolution of inherited retinal diseases natural history registry (VENTURE study): rationale, methodology and initial participant characteristics. Clin Exp Ophthalmol 2022; 50: 768–780. doi:10.1111/ceo.14110.
   PubMed Web of Science ®Google Scholar
• Halioua-Haubold C-L, Jolly JK, Smith JA et al. Potential lifetime quality of life benefits of choroideremia gene therapy: projections from a clinically informed decision model. Eye 2019; 33: 1215–1223. doi:10.1038/s41433-019-0492-1.
   PubMed Web of Science ®Google Scholar
• Maguire AM, High KA, Auricchio A et al. Age-dependent effects of RPE65 gene therapy for Leber’s congenital amaurosis: a phase 1 dose-escalation trial. Lancet 2009; 374: 1597–1605. doi:10.1016/S0140-6736(09)61836-5.
   PubMed Web of Science ®Google Scholar
• Jolly JK, Bridge H, MacLaren RE. Outcome measures used in ocular gene therapy trials: a scoping review of current practice. Front Pharmacol 2019; 10: 509–519. doi:10.3389/fphar.2019.01076.
   PubMed Web of Science ®Google Scholar
• Thompson DA, Ali RR, Banin E et al. Advancing therapeutic strategies for inherited retinal degeneration: recommendations from the monaciano symposium. Invest Ophthalmol Visual Sci 2015; 56: 918–931. doi:10.1167/iovs.14-16049.
   PubMed Web of Science ®Google Scholar
• Ţălu Ş, Ţǎlu M, Giovanzana S et al. The history and use of optical coherence tomography in ophthalmology. Hum Vet Med 2011; 3: 29–32.
   Google Scholar
• Potsaid B, Gorczynska I, Srinivasan VJ et al. Ultrahigh speed spectral/fourier domain OCT ophthalmic imaging at 70,000 to 312,500 axial scans per second. Opt Express 2008; 16: 15149. doi:10.1364/OE.16.015149.
   PubMed Web of Science ®Google Scholar
• Cicinelli MV, Marchese A, Bordato A et al. Reviewing the role of ultra-widefield imaging in inherited retinal dystrophies. Ophthalmol Ther 2020; 9: 249–263. doi:10.1007/s40123-020-00241-1.
   PubMed Web of Science ®Google Scholar
• Georgiou M, Kalitzeos A, Patterson EJ et al. Adaptive optics imaging of inherited retinal diseases. Br J Ophthalmol 2018; 102: 1028–1035. doi:10.1136/bjophthalmol-2017-311328.
   PubMed Web of Science ®Google Scholar
• Muftuoglu IK, Al-Sheikh M, S J et al. Imaging in inherited retinal disorders. Eur J Ophthalmol 2021; 31: 1656–1676. doi:10.1177/1120672121990578.
   PubMed Web of Science ®Google Scholar
• Sabbaghi H, Ahmadieh H, Jalili J et al. Choroidal thickness in different types of inherited retinal dystrophies. J Ophthalmic Vis Res 2020; 15: 351. doi:10.18502/jovr.v15i3.7454.
   PubMed Web of Science ®Google Scholar
• Jayanna S, Jalali S, Padhi TR et al. OCT imaging in infants. Semin Ophthalmol 2022; 37: 358–372. doi:10.1080/08820538.2021.1970781.
   PubMed Web of Science ®Google Scholar
• Staurenghi G, Sadda S, Chakravarthy U et al. Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: the in OCT consensus. Ophthalmology 2014; 121: 1572–1578. doi:10.1016/j.ophtha.2014.02.023.
   PubMed Web of Science ®Google Scholar
• Kong X, Ho A, Munoz B et al. Reproducibility of measurements of retinal structural parameters using optical coherence tomography in stargardt disease. Transl Vis Sci Technol 2019; 8: 46. doi:10.1167/tvst.8.3.46.
   PubMed Web of Science ®Google Scholar
• Ervin AM, Strauss RW, Ahmed MI et al. A workshop on measuring the progression of atrophy secondary to Stargardt disease in the ProgStar Studies: findings and lessons learned. Transl Vis Sci Technol 2019; 8: 16–16. doi:10.1167/tvst.8.2.16.
   PubMed Web of Science ®Google Scholar
• Velaga SB, Nittala MG, Jenkins D et al. Impact of segmentation density on spectral domain optical coherence tomography assessment in Stargardt disease. Graefes Arch Clin Exp Ophthalmol 2019; 257: 549–556. doi:10.1007/s00417-018-04229-3.
   PubMed Web of Science ®Google Scholar
• Lang A, Carass A, Bittner AK et al. Improving graph-based OCT segmentation for severe pathology in retinitis pigmentosa patients. In: Krol A, and Gimi B, editors. Proceedings of SPIE–the International Society for Optical Engineering, San Diego, USA. NIH Public Access. p. 101371M.
   Google Scholar
• Tanna P, Strauss RW, Fujinami K et al. Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options. Br J Ophthalmol 2017; 101: 25–30. doi:10.1136/bjophthalmol-2016-308823.
   PubMed Web of Science ®Google Scholar
• Tanna P, Georgiou M, Strauss RW et al. Cross-sectional and longitudinal assessment of the ellipsoid zone in childhood-onset Stargardt disease. Transl Vis Sci Technol 2019; 8: 1. doi:10.1167/tvst.8.2.1.
   PubMed Web of Science ®Google Scholar
• Fujinami K, Zernant J, Chana RK et al. Clinical and molecular characteristics of childhood-onset Stargardt disease. Ophthalmology 2015; 122: 326–334. doi:10.1016/j.ophtha.2014.08.012.
   PubMed Web of Science ®Google Scholar
• Huang WC, Cideciyan AV, Roman AJ et al. Inner and outer retinal changes in retinal degenerations associated with ABCA4 mutations. Invest Ophthalmol Vis Sci 2014; 55: 1810. doi:10.1167/iovs.13-13768.
   PubMedGoogle Scholar
• Cai CX, Light JG, Handa JT. Quantifying the rate of ellipsoid zone loss in Stargardt disease. Am J Ophthalmol 2018; 186: 1–9. doi:10.1016/j.ajo.2017.10.032.
   PubMed Web of Science ®Google Scholar
• Burke TR, Yzer S, Zernant J et al. Abnormality in the external limiting membrane in early Stargardt disease. Ophthalmic Genet 2013; 34: 75–77. doi:10.3109/13816810.2012.707271.
   PubMed Web of Science ®Google Scholar
• Lee W, Nõupuu K, Oll M et al. The external limiting membrane in early-onset Stargardt disease. Invest Ophthalmol Vis Sci 2014; 55: 6139. doi:10.1167/iovs.14-15126.
   PubMed Web of Science ®Google Scholar
• Khan KN, Kasilian M, Mahroo OAR et al. Early patterns of macular degeneration in ABCA4-associated retinopathy. Ophthalmology 2018; 125: 735–746. doi:10.1016/j.ophtha.2017.11.020.
   PubMed Web of Science ®Google Scholar
• Palejwala NV, Gale MJ, Clark RF et al. Insights into autosomla dominant Stargardt-like macular dystrophy through multimodality diagnostic imaging. Retina 2016; 36: 119–130. doi:10.1097/IAE.0000000000000659.
   PubMed Web of Science ®Google Scholar
• Spaide RF, Noble K, Morgan A et al. Vitelliform macular dystrophy. Ophthalmology 2006; 113: 1392–1400.e4. doi:10.1016/j.ophtha.2006.03.023.
   PubMed Web of Science ®Google Scholar
• Bianco L, Arrigo A, Antropoli A et al. Multimodal imaging in Best vitelliform macular dystrophy: literature review and novel insights. Eur J Ophthalmol 2023: 112067212311664. doi:10.1177/11206721231166434.
   Web of Science ®Google Scholar
• Johnson AA, Guziewicz KE, Lee CJ et al. Bestrophin 1 and retinal disease. Prog Retin Eye Res 2017; 58: 45–69. doi:10.1016/j.preteyeres.2017.01.006.
   PubMed Web of Science ®Google Scholar
• Sayman Muslubas I, Arf S, Hocaoglu M et al. Best disease presenting as subretinal pigment epithelium hyperreflectivite lesion on spectral-domain optical coherence tomography: multimodal imaging features. Eur J Ophthalmol 2022; 32: 2702–2711. doi:10.1177/11206721211055961.
   PubMed Web of Science ®Google Scholar
• Dhoble P, Robson AG, Webster AR et al. Typical best vitelliform dystrophy secondary to biallelic variants in BEST1. Ophthalmic Genet 2023: 1–6. doi:10.1080/13816810.2023.2188227.
   PubMed Web of Science ®Google Scholar
• Griffith JF, Hess DJ, Berrocal AM. Best’s vitelliform macular dystrophy in 10- and 31-month-old siblings. J Pediatr Ophthalmol Strabismus 2014; 51: e8–e12. doi:10.3928/01913913-20140225-01.
   PubMed Web of Science ®Google Scholar
• den Hollander AI, Roepman R, Koenekoop RK et al. Leber congenital amaurosis: genes, proteins and disease mechanisms. Prog Retin Eye Res 2008; 27: 391–419. doi:10.1016/j.preteyeres.2008.05.003.
   PubMed Web of Science ®Google Scholar
• Aleman TS, Jacobson SG, Chico JD et al. Impairment of the transient pupillary light reflex in Rpe65−/− mice and humans with Leber congenital amaurosis. Invest Ophthalmol Visual Sci 2004; 45: 1259–1271. doi:10.1167/iovs.03-1230.
   PubMed Web of Science ®Google Scholar
• Simonelli F, Ziviello C, Testa F et al. Clinical and molecular genetics of Leber’s congenital amaurosis: a multicenter study of Italian patients. Invest Ophthalmol Vis Sci 2007; 48: 4284. doi:10.1167/iovs.07-0068.
   PubMed Web of Science ®Google Scholar
• Tsang SH, Sharma T. Leber congenital amaurosis. Adv Exp Med Biol 2018; 131–137.
   Google Scholar
• Fazzi E, Signorini SG, Scelsa B et al. Leber’s congenital amaurosis: an update. Eur J Paediatr Neuro 2003; 7: 13–22. doi:10.1016/S1090-3798(02)00135-6.
   PubMed Web of Science ®Google Scholar
• Yang H, Yu T, Sun C et al. Spectral-domain optical coherence tomography in patients with congenital nystagmus. Int J Ophthalmol 2011; 4: 627–630. doi:10.3980/j.issn.2222-3959.2011.06.10.
   PubMed Web of Science ®Google Scholar
• Maguire AM, Simonelli F, Pierce EA et al. Safety and efficacy of gene transfer for Leber’s congenital amaurosis. N Engl J Med 2008; 358: 2240–2248. doi:10.1056/NEJMoa0802315.
   PubMed Web of Science ®Google Scholar
• Jacobson SG, Aleman TS, Cideciyan AV et al. Human cone photoreceptor dependence on RPE65 isomerase. Proc Natl Acad Sci USA 2007; 104: 15123–15128. doi:10.1073/pnas.0706367104.
   PubMed Web of Science ®Google Scholar
• Jacobson SG, Cideciyan AV, Huang WC et al. Leber congenital amaurosis: genotypes and retinal structure phenotypes. Adv Exp Med Biol 2016; 169–175.
   PubMed Web of Science ®Google Scholar
• Jacobson SG, Cideciyan AV, Aleman TS et al. Photoreceptor layer topography in children with Leber congenital amaurosis caused by RPE65 mutations. Invest Ophthalmol Vis Sci 2008; 49: 4573. doi:10.1167/iovs.08-2121.
   PubMed Web of Science ®Google Scholar
• Miyamichi D, Nishina S, Hosono K et al. Retinal structure in Leber’s congenital amaurosis caused by RPGRIP1 mutations. Hum Genome Var 2019; 6: 32. doi:10.1038/s41439-019-0064-8.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang Q, Zhang X et al. Clinical and genetic characteristics of Leber congenital amaurosis with novel mutations in known genes based on a Chinese eastern coast Han population. Graefes Arch Clin Exp Ophthalmol 2016; 254: 2227–2238. doi:10.1007/s00417-016-3428-5.
   PubMed Web of Science ®Google Scholar
• Bouzia Z, Georgiou M, Hull S et al. GUCY2D-associated Leber congenital amaurosis: a retrospective natural history study in preparation for trials of novel therapies. Am J Ophthalmol 2020; 210: 59–70. doi:10.1016/j.ajo.2019.10.019.
   PubMed Web of Science ®Google Scholar
• Pasadhika S, Fishman GA, Stone EM et al. Differential macular morphology in patients with RPE65 -, CEP290 -, GUCY2D -, and AIPL1 -related leber congenital amaurosis. Invest Ophthalmol Vis Sci 2010; 51: 2608. doi:10.1167/iovs.09-3734.
   PubMed Web of Science ®Google Scholar
• Jacobson SG, Cideciyan AV, Peshenko IV et al. Determining consequences of retinal membrane guanylyl cyclase (RetGC1) deficiency in human Leber congenital amaurosis en route to therapy: residual cone-photoreceptor vision correlates with biochemical properties of the mutants. Hum Mol Genet 2013; 22: 168–183. doi:10.1093/hmg/dds421.
   PubMed Web of Science ®Google Scholar
• Sankila E-M, Tolvanen R, van den Hurk JAJM et al. Aberrant splicing of the CHM gene is a significant cause of choroideremia. Nat Genet 1992; 1: 109–113. doi:10.1038/ng0592-109.
   PubMed Web of Science ®Google Scholar
• Tsang SH, Sharma T. X-linked choroideremia. Adv Exp Med Biol 2018: 37–42.
   PubMed Web of Science ®Google Scholar
• Jolly JK, Edwards TL, Moules J et al. A qualitative and quantitative assessment of fundus autofluorescence patterns in patients with choroideremia. Invest Ophthalmol Vis Sci 2016; 57: 4498. doi:10.1167/iovs.15-18362.
   PubMed Web of Science ®Google Scholar
• Xue K, Oldani M, Jolly JK et al. Correlation of optical coherence tomography and autofluorescence in the outer retina and choroid of patients with choroideremia. Invest Ophthalmol Vis Sci 2016; 57: 3674. doi:10.1167/iovs.15-18364.
   PubMed Web of Science ®Google Scholar
• Foote KG, Roorda A, Duncan JL. Multimodal imaging in choroideremia. 2019. p. 139–143.
   Google Scholar
• Aleman TS, Han G, Serrano LW et al. Natural history of the central structural abnormalities in choroideremia. Ophthalmology 2017; 124: 359–373. doi:10.1016/j.ophtha.2016.10.022.
   PubMed Web of Science ®Google Scholar
• Jacobson SG, Cideciyan AV, Sumaroka A et al. Remodeling of the human retina in choroideremia: Rab Escort Protein 1 (REP-1) mutations. Invest Ophthalmol Vis Sci 2006; 47: 4113. doi:10.1167/iovs.06-0424.
   PubMed Web of Science ®Google Scholar
• Khan KN, Islam F, Moore AT et al. Clinical and genetic features of choroideremia in childhood. Ophthalmology 2016; 123: 2158–2165. doi:10.1016/j.ophtha.2016.06.051.
   PubMed Web of Science ®Google Scholar
• Murro V, Mucciolo DP, Giorgio D et al. Optical coherence tomography angiography (OCT-A) in young choroideremia (CHM) patients. Ophthalmic Genet 2019; 40: 201–206. doi:10.1080/13816810.2019.1611880.
   PubMed Web of Science ®Google Scholar
• Abbouda A, Dubis AM, Webster AR et al. Identifying characteristic features of the retinal and choroidal vasculature in choroideremia using optical coherence tomography angiography. Eye 2018; 32: 563–571. doi:10.1038/eye.2017.242.
   PubMed Web of Science ®Google Scholar
• Battaglia Parodi M, Arrigo A, MacLaren RE et al. Vascular alterations revealed with optical coherence tomography angiography in patients with choroideremia. Retina 2019; 39: 1200–1205. doi:10.1097/IAE.0000000000002118.
   PubMed Web of Science ®Google Scholar
• Mansour AM, Elnahry AG, Tripathy K et al. Analysis of optical coherence angiography in cystoid macular oedema associated with gyrate atrophy. Eye 2021; 35: 1766–1774. doi:10.1038/s41433-020-01166-6.
   PubMed Web of Science ®Google Scholar
• Murro V, Mucciolo DP, Giorgio D et al. Choroidal vascularity index in young choroideremia patients. Retina 2021; 41: 1018–1025. doi:10.1097/IAE.0000000000002960.
   PubMed Web of Science ®Google Scholar
• Read SA, Collins MJ, Vincent SJ et al. Choroidal thickness in childhood. Invest Ophthalmol Vis Sci 2013; 54: 3586. doi:10.1167/iovs.13-11732.
   PubMed Web of Science ®Google Scholar
• Gerena Arévalo VA, Ruiz-Moreno JM. Choroidal thickness in a hyperopic pediatric population. Diagnostics 2022; 12: 2330. doi:10.3390/diagnostics12102330.
   Web of Science ®Google Scholar
• Liu Y, Wang L, Xu Y et al. The influence of the choroid on the onset and development of myopia: from perspectives of choroidal thickness and blood flow. Acta Ophthalmol 2021; 99: 730–738. doi:10.1111/aos.14773.
   PubMed Web of Science ®Google Scholar
• Talib M, van Schooneveld MJ, Thiadens AA et al. Clinical and genetic characteristics of male patients with RPGR-associated retinal dystrophies: a long term follow up study. Retina 2019; 39: 1186–1199. doi:10.1097/IAE.0000000000002125.
   PubMed Web of Science ®Google Scholar
• Talib M, van Schooneveld MJ, Van Cauwenbergh C et al. The spectrum of structural and functional abnormalities in female carriers of pathogenic variants in the RPGR gene. Invest Ophthalmol Vis Sci 2018; 59: 4123. doi:10.1167/iovs.17-23453.
   PubMed Web of Science ®Google Scholar
• Kortüm F, Kieninger S, Mazzola P et al. X-Linked retinitis pigmentosa caused by non-canonical splice site variants in RPGR. Int J Mol Sci 2021; 22: 850. doi:10.3390/ijms22020850.
   PubMed Web of Science ®Google Scholar
• Menghini M, Jolly JK, Nanda A et al. Early cone photoreceptor outer segment length shortening in RPGR X-linked retinitis pigmentosa. Ophthalmologica 2021; 244: 281–290. doi:10.1159/000507484.
   PubMed Web of Science ®Google Scholar
• Birch DG, Locke KG, Felius J et al. Rates of decline in regions of the visual field defined by frequency-domain optical coherence tomography in patients with RPGR-mediated X-linked retinitis pigmentosa. Ophthalmology 2015; 122: 833–839. doi:10.1016/j.ophtha.2014.11.005.
   PubMed Web of Science ®Google Scholar
• Kousal B, Skalicka P, Valesova L et al. Severe retinal degeneration in women with a c.2543del mutation in ORF15 of the RPGR gene. Mol Vis 2014; 20: 1307–1317. doi:10.1111/j.1755-3768.2014.T070.x.
   PubMed Web of Science ®Google Scholar
• Shifera AS, Kay CN. Early-onset X-linked retinitis pigmentosa in a heterozygous female harboring an intronic donor splice site mutation in the retinitis pigmentosa GTPase regulator gene. Ophthalmic Genet 2015; 36: 251–256. doi:10.3109/13816810.2013.879597.
   PubMed Web of Science ®Google Scholar
• Neidhardt J, Glaus E, Lorenz B et al. Identification of novel mutations in X-linked retinitis pigmentosa families and implications for diagnostic testing. Mol Vis 2008; 14: 1081–1093.
   PubMed Web of Science ®Google Scholar
• Souied E, Segues B, Ghazi I et al. Severe manifestations in carrier females in X linked retinitis pigmentosa. J Med Genet 1997; 34: 793–797. doi:10.1136/jmg.34.10.793.
   PubMed Web of Science ®Google Scholar
• Kremlikova Pourova R, Paderova J, Copikova J et al. SD-OCT imaging as a valuable tool to support molecular genetic diagnostics of Usher syndrome type 1. J Am Assoc Pediatr Ophthalmol Strabismus 2018; 22: 312–314.e3. doi:10.1016/j.jaapos.2017.12.009.
   Google Scholar
• Mathur P, Yang J. Usher syndrome: hearing loss, retinal degeneration and associated abnormalities. Biochimic et Biophys Acta 2015; 1852: 406–420. doi:10.1016/j.bbadis.2014.11.020.
   PubMed Web of Science ®Google Scholar
• Testa F, Melillo P, Bonnet C et al. Clinical presentation and disease course of Usher syndrome because of mutations in MYO7A or USH2A. Retina 2017; 37: 1581–1590. doi:10.1097/IAE.0000000000001389.
   PubMed Web of Science ®Google Scholar
• Feenstra HM, Al-Khuzaei S, Shah M et al. Phenotypic and genetic characteristics in a cohort of patients with Usher genes. Genes (Basel) 2022; 13: 1423. doi:10.3390/genes13081423.
   PubMed Web of Science ®Google Scholar
• Joensuu T, Hämäläinen R, Yuan B et al. Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3. Am J Hum Genet 2001; 69: 673–684. doi:10.1086/323610.
   PubMed Web of Science ®Google Scholar
• Peter VG, Quinodoz M, Sadio S et al. New clinical and molecular evidence linking mutations in ARSG to Usher syndrome type IV. Hum Mutat 2021; 42: 261–271. doi:10.1002/humu.24150.
   PubMed Web of Science ®Google Scholar
• Lad EM, Duncan JL, Liang W et al. Baseline microperimetry and OCT in the RUSH2A study: structure−function association and correlation with disease severity. Am J Ophthalmol 2022; 244: 98–116. doi:10.1016/j.ajo.2022.08.013.
   PubMed Web of Science ®Google Scholar
• Lenassi E, Saihan Z, Cipriani V et al. Natural history and retinal structure in patients with Usher syndrome type 1 owing to MYO7A mutation. Ophthalmology 2014; 121: 580–587. doi:10.1016/j.ophtha.2013.09.017.
   PubMed Web of Science ®Google Scholar
• Subirà O, Català-Mora J, Díaz-Cascajosa J et al. Retinal findings in pediatric patients with Usher syndrome type 1 due to mutations in MYO7A gene. Eye 2020; 34: 499–506. doi:10.1038/s41433-019-0536-6.
   PubMed Web of Science ®Google Scholar
• Malm E, Ponjavic V, Möller C et al. Alteration of rod and cone function in children with Usher syndrome. Eur J Ophthalmol 2011; 21: 30–38. doi:10.5301/EJO.2010.5433.
   PubMed Web of Science ®Google Scholar
• Sliesoraityte I, Peto T, Mohand-Said S et al. Novel grading system for quantification of cystic macular lesions in Usher syndrome. Orphanet J Rare Dis 2015; 10: 157. doi:10.1186/s13023-015-0372-0.
   PubMed Web of Science ®Google Scholar
• George ND, Yates JR, Moore AT. X linked retinoschisis. Br J Ophthalmol 1995; 79: 697–702. doi:10.1136/bjo.79.7.697.
   PubMed Web of Science ®Google Scholar
• Molday RS, Kellner U, Weber BHF. X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms. Prog Retin Eye Res 2012; 31: 195–212. doi:10.1016/j.preteyeres.2011.12.002.
   PubMed Web of Science ®Google Scholar
• Murro V, Caputo R, Bacci GM et al. Case report of an atypical early onset X-linked retinoschisis in monozygotic twins. BMC Ophthalmol 2017; 17: 19. doi:10.1186/s12886-017-0406-6.
   PubMed Web of Science ®Google Scholar
• Strupaitė R, Ambrozaitytė L, Cimbalistienė L et al. X-linked juvenile retinoschisis: phenotypic and genetic characterization. Int J Ophthalmol 2018; 11: 1875. doi:10.18240/ijo.2018.11.22.
   PubMed Web of Science ®Google Scholar
• Altschwager P, Ambrosio L, Swanson EA et al. Juvenile macular degenerations. Semin Pediatr Neurol 2017; 24: 104–109. doi:10.1016/j.spen.2017.05.005.
   PubMed Web of Science ®Google Scholar
• Lee JJ, Kim JH, Kim SY et al. Infantile vitreous hemorrhage as the initial presentation of X-linked juvenile retinoschisis. Korean J Ophthalmol 2009; 23: 118. doi:10.3341/kjo.2009.23.2.118.
   PubMedGoogle Scholar
• Prasad A, Wagner R, Bhagat N. Vitreous hemorrhage as the initial manifestation of X-linked retinoschisis in a 9-month-old infant. J Pediatr Ophthalmol Strabismus 2006; 43: 56.
   PubMed Web of Science ®Google Scholar
• Gao F, Dong J, Wang D et al. Comprehensive analysis of genetic and clinical characteristics of 30 patients with X‐linked juvenile retinoschisis in China. Acta Ophthalmol 2021; 99: e470–e479. doi:10.1111/aos.14642.
   PubMed Web of Science ®Google Scholar
• Han IC, Whitmore SS, Critser DB et al. Wide-field swept-source OCT and angiography in X-linked retinoschisis. Ophthalmol Retina 2019; 3: 178–185. doi:10.1016/j.oret.2018.09.006.
   PubMedGoogle Scholar
• Hu Q, Huang L, Chen X et al. X-linked retinoschisis in juveniles: follow-up by optical coherence tomography. Biomed Res Int 2017; 2017: 1–5. doi:10.1155/2017/1704623.
   Web of Science ®Google Scholar
• Huang L, Sun L, Wang Z et al. Clinical manifestation and genetic analysis in Chinese early onset X‐linked retinoschisis. Molec Gen & Gen Med 2020; 8: e1421. doi:10.1002/mgg3.1421.
   PubMed Web of Science ®Google Scholar
• Ling KP, Mangalesh S, Tran-Viet D et al. Handheld spectral domain optical coherence tomography findings of X-Linked retinoschisis in early childhood. Retina 2020; 40: 1996–2003. doi:10.1097/IAE.0000000000002688.
   PubMedGoogle Scholar
• Padrón-Pérez N, Català-Mora J, Díaz J et al. Swept-source and optical coherence tomography angiography in patients with X-linked retinoschisis. Eye 2018; 32: 707–715. doi:10.1038/eye.2017.281.
   PubMed Web of Science ®Google Scholar
• Yu J, Ni Y, Keane PA et al. Foveomacular schisis in juvenile X-linked retinoschisis: an optical coherence tomography study. Am J Ophthalmol 2010; 149: 973–978.e2. doi:10.1016/j.ajo.2010.01.031.
   PubMed Web of Science ®Google Scholar
• Smith LM, Cernichiaro-Espinosa LA, McKeown CA et al. X-linked peripheral retinoschisis without macular involvement: a case series with RS1 genetic confirmation. Ophthalmic Genet 2020; 41: 57–62. doi:10.1080/13816810.2020.1723115.
   PubMed Web of Science ®Google Scholar
• Apushkin MA, Fishman GA, Janowicz MJ. Correlation of optical coherence tomography findings with visual acuity and macular lesions in patients with X-linked retinoschisis. Ophthalmology 2005; 112: 495–501. doi:10.1016/j.ophtha.2004.08.027.
   PubMed Web of Science ®Google Scholar
• Kjellström S, Vijayasarathy C, Ponjavic V et al. Long-term 12 year follow-up of X-linked congenital retinoschisis. Ophthalmic Genet 2010; 31: 114–125. doi:10.3109/13816810.2010.482555.
   PubMed Web of Science ®Google Scholar
• Takada Y, Fariss RN, Tanikawa A et al. A retinal neuronal developmental wave of retinoschisin expression begins in ganglion cells during layer formation. Invest Ophthalmol Vis Sci 2004; 45: 3302. doi:10.1167/iovs.04-0156.
   PubMed Web of Science ®Google Scholar
• Yang HS, Lee JB, Yoon YH et al. Correlation between spectral-domain OCT findings and visual acuity in X-linked retinoschisis. Invest Ophthalmol Vis Sci 2014; 55: 3029. doi:10.1167/iovs.14-13955.
   PubMed Web of Science ®Google Scholar
• Mole S, Williams R, Goebel H. The neuronal ceroid lipofuscinoses (Batten disease). Oxford, UK: Oxford University Press; 2011.
   Google Scholar
• Kleine Holthaus S-M, Aristorena M, Maswood R et al. Gene therapy targeting the inner retina rescues the retinal phenotype in a mouse model of CLN3 Batten disease. Hum Gene Ther 2020; 31: 709–718. doi:10.1089/hum.2020.038.
   PubMed Web of Science ®Google Scholar
• Hansen MS, Hove MN, Jensen H et al. Optical coherence tomography in juvenile neuronal ceroid lipofuscinosis. Retin Cases Brief Rep 2016; 10: 137–139. doi:10.1097/ICB.0000000000000200.
   PubMedGoogle Scholar
• Lebrun A-H, Moll-Khosrawi P, Pohl S et al. Analysis of potential biomarkers and modifier genes affecting the clinical course of CLN3 disease. Mol Med 2011; 17: 1253–1261. doi:10.2119/molmed.2010.00241.
   PubMed Web of Science ®Google Scholar
• Adams HR, Rose K, Augustine EF et al. Experience, knowledge, and opinions about childhood genetic testing in Batten disease. Mol Genet Metab 2014; 111: 197–202. doi:10.1016/j.ymgme.2013.10.017.
   PubMed Web of Science ®Google Scholar
• Kovacs KD, Orlin A, Sondhi D et al. Automated retinal layer segmentation in CLN2-associated disease: commercially available software characterizing a progressive maculopathy. Transl Vis Sci Technol 2021; 10: 23. doi:10.1167/tvst.10.8.23.
   PubMed Web of Science ®Google Scholar
• Kuper WFE, Talsma HE, van Schooneveld MJ et al. Recognizing differentiating clinical signs of CLN3 disease (Batten disease) at presentation. Acta Ophthalmol 2021; 99: 397–404. doi:10.1111/aos.14630.
   PubMed Web of Science ®Google Scholar
• Wright GA, Georgiou M, Robson AG et al. Juvenile Batten disease (CLN3): detailed ocular phenotype, novel observations, delayed diagnosis, masquerades, and prospects for therapy. Ophthalmol Retina 2020; 4: 433–445. doi:10.1016/j.oret.2019.11.005.
   PubMedGoogle Scholar
• Preising MN, Abura M, Jäger M et al. Ocular morphology and function in juvenile neuronal ceroid lipofuscinosis (CLN3) in the first decade of life. Ophthalmic Genet 2017; 38: 252–259. doi:10.1080/13816810.2016.1210651.
   PubMed Web of Science ®Google Scholar
• Kovacs KD, Patel S, Orlin A et al. Symmetric age association of retinal degeneration in patients with CLN2-associated Batten disease. Ophthalmol Retina 2020; 4: 728–736. doi:10.1016/j.oret.2020.01.011.
   PubMedGoogle Scholar
• Orlin A, Sondhi D, Witmer MT et al. Spectrum of ocular manifestations in CLN2-associated Batten (Jansky-Bielschowsky) disease correlate with advancing age and deteriorating neurological function. PloS ONE 2013; 8: e73128. doi:10.1371/journal.pone.0073128.
   PubMed Web of Science ®Google Scholar
• Dulz S, Atiskova Y, Wibbeler E et al. An ophthalmic rating scale to assess ocular involvement in juvenile CLN3 disease. Am J Ophthalmol 2020; 220: 64–71. doi:10.1016/j.ajo.2020.07.015.
   PubMed Web of Science ®Google Scholar
• Grigg J, Jamieson R, Chen F et al. Guidelines for the assessment and management of patients with inherited retinal diseases (IRD). 2020 [accessed 2023 Nov 7]. https://ranzco.edu/?s=Guidelines+for+the+assessment+and+management+of+patients+with+inherited+retinal+degenerations.
   Google Scholar
• Berger W, Kloeckener-Gruissem B, Neidhardt J. The molecular basis of human retinal and vitreoretinal diseases. Prog Retin Eye Res 2010; 29: 335–375. doi:10.1016/j.preteyeres.2010.03.004.
   PubMed Web of Science ®Google Scholar
• Kumaran N, Georgiou M, Bainbridge JWB et al. Retinal structure in RPE65-associated retinal dystrophy. Invest Ophthalmol Vis Sci 2020; 61: 47. doi:10.1167/iovs.61.4.47.
   PubMed Web of Science ®Google Scholar